/
BIOL
$0.02-$0.04 (-72.06%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Price (6 mo)
Loading chart…
Change$-1747.73
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $51.8M | $46.9M | $46.2M | $37.8M | $22.8M | $39.2M | $48.5M | $49.2M |
| Cost of revenue | $31.5M | $31.8M | $29.3M | $23.5M | $16.6M | $22.7M | $32.6M | $32.4M |
| Gross profit | $20.3M | $15.1M | $16.9M | $14.3M | $6.2M | $16.5M | $15.9M | $16.7M |
| Gross margin | 39.2% | 32.2% | 36.6% | 37.8% | 27.1% | 42.2% | 32.8% | 34.0% |
| R&D | $7.8M | $6.2M | $5.2M | $4.8M | $3.7M | $6.0M | $7.3M | $6.0M |
| Operating income | −$15.0M | −$18.0M | −$20.9M | −$15.6M | −$18.5M | −$16.1M | −$25.3M | −$17.9M |
| EBITDA | −$13.9M | −$16.3M | −$17.3M | −$14.8M | −$13.8M | −$13.5M | −$25.3M | −$15.4M |
| Net income | −$15.4M | −$16.9M | −$21.5M | −$17.9M | −$16.8M | −$16.2M | −$28.6M | −$20.6M |
| Net margin | -29.7% | -35.9% | -46.6% | -47.2% | -73.9% | -41.2% | -59.1% | -42.0% |
| EPS (diluted) | -3167.32 | -2856.10 | -2612.75 | -1923.95 | -688.19 | -273.41 | -413.19 | -16.14 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Held by traders on TradeandTell
No one on the platform currently holds BIOL.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIOL as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-07-28 | 1-for-100reverse |
| 2022-04-29 | 1-for-25reverse |
| 2018-05-11 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded BIOL yet.
